Should patients with low‐risk renal cell carcinoma be followed differently after nephron‐sparing surgery vs radical nephrectomy?

Author:

Abu‐Ghanem Yasmin1ORCID,Powles Thomas2,Capitanio Umberto3ORCID,Beisland Christian45,Järvinen Petrus6,Stewart Grant D.7,Gudmundsson Eirikur8,Lam Thomas B.L.9,Marconi Lorenzo10,Fernandéz‐Pello Sergio11ORCID,Nisen Harry6ORCID,Meijer Richard P.12,Volpe Alessandro13,Ljungberg Börje14,Klatte Tobias715ORCID,Bensalah Karim16,Dabestani Saeed17,Bex Axel118

Affiliation:

1. UCL Division of Surgical and Interventional Science Specialist Centre for Kidney Cancer Royal Free London NHS Foundation Trust LondonUK

2. Barts Cancer Institute Queen Mary University of London London UK

3. Division of Experimental Oncology Urological Research Institute (URI) IRCCS Ospedale San Raffaele Milan Italy

4. Department of Urology Haukeland University Hospital BergenNorway

5. Department of Clinical Medicine University of Bergen Bergen Norway

6. Urology Abdominal Centre University of Helsinki and Helsinki University Hospital Helsinki Finland

7. Department of Surgery University of Cambridge Cambridge UK

8. Department of Urology Landspitali University Hospital Reykjavik Iceland

9. Academic Urology Unit University of Aberdeen Aberdeen UK

10. Department of Urology Coimbra University Hospital Coimbra Portugal

11. Department of Urology Cabueñes University Hospital Gijón Spain

12. Department of Oncological Urology University Medical Centre Utrecht Utrecht The Netherlands

13. Department of Urology Maggiore della Carità Hospital University of Eastern Piedmont Novara Italy

14. Department of Surgical and Perioperative Sciences Umeå University Umeå Sweden

15. Department of Urology Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust Bournemouth UK

16. Department of Urology University Hospital of Rennes Rennes France

17. Division of Urological Cancers Department of Translational Medicine Central Hospital Kristianstad Lund University Lund Sweden

18. Department of Urology Netherlands Cancer Institute Amsterdam The Netherlands

Publisher

Wiley

Subject

Urology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3